David A. Gewirtz
- Physiology top 0.5%
- Telomeres, Telomerase, and Senescence 38
- Oncology top 1%
- Cancer-related Molecular Pathways 23
- PARP inhibition in cancer therapy 17
- Cancer Research top 2%
- Physiology top 1%
- Telomeres, Telomerase, and Senescence 38
- Molecular Biology top 1%
- DNA Repair Mechanisms 20
- Cancer therapeutics and mechanisms 19
- Retinoids in leukemia and cellular processes 12
-
- Autophagy in Disease and Therapy 50
-
- Cannabis and Cannabinoid Research 14
- Co-authors
- Tareq SalehFrank A. FornariLynne W. ElmoreXu DiJoyce K. RandolphShawn E. HoltSteven GrantW. David Jarvis
- Cited by
- PhysiologyOncologyCancer Research
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (3 papers)Circulation (3 papers)
- Partner nations
- United StatesJordanEgypt
In The Last Decade
David A. Gewirtz
189 papers receiving 8.0k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Physiology 383
- Oncology 2.2k
- Cancer Research 1.1k
- Physiology 1.7k
- Molecular Biology 4.4k
Countries citing papers authored by David A. Gewirtz
This map shows the geographic impact of David A. Gewirtz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Gewirtz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Gewirtz more than expected).
Fields of papers citing papers by David A. Gewirtz
This network shows the impact of papers produced by David A. Gewirtz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Gewirtz. The network helps show where David A. Gewirtz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David A. Gewirtz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 15 | |
| 5 | 2023 | 10 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 22 | |
| 9 | 2021 | 10 | |
| 10 | 2019 | 33 | |
| 11 | 2018 | 128 | |
| 12 | 2018 | 20 | |
| 13 | 2017 | 115 | |
| 14 | 2015 | 29 | |
| 15 | Abstract 14880: Interleukin-18 in Radiation-induced Cardiomyopathy | 2014 | 1 |
| 16 | Abstract 14774: Preserved Left Ventricular Contractile Reserve After Thoracic Irradiation in the Interleukin-1 Receptor Knock Out Mouse | 2013 | 1 |
| 17 | Abstract 17799: Role Of Interleukin-1 In Acute Radiation-induced Cardiomyopathy | 2012 | 1 |
| 18 | 2007 | 23 | |
| 19 | 1996 | 9 | |
| 20 | 1990 | 12 |
About David A. Gewirtz
David A. Gewirtz is a scholar working on Oncology, Physiology and Geriatrics and Gerontology, having authored 192 papers that have together received 8.1k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (50 papers), Telomeres, Telomerase, and Senescence (38 papers), Cancer-related Molecular Pathways (23 papers), DNA Repair Mechanisms (20 papers), Cancer therapeutics and mechanisms (19 papers), PARP inhibition in cancer therapy (17 papers), Cannabis and Cannabinoid Research (14 papers) and Retinoids in leukemia and cellular processes (12 papers). The work is most often cited by research in Physiology (383 citations), Oncology (2.2k citations) and Cancer Research (1.1k citations). David A. Gewirtz has collaborated with scholars based in United States, Jordan and Egypt. Frequent co-authors include Tareq Saleh, Frank A. Fornari, Lynne W. Elmore, Xu Di, Joyce K. Randolph, Shawn E. Holt, Steven Grant, W. David Jarvis, Liliya Tyutyunyk‐Massey and Richard Kolesnick. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.